Efficacy of deep brain stimulation of the subthalamic nucleus in Parkinson’s disease 4 years after surgery: double blind and open label evaluation

Objective: To evaluate the long term (4 years) efficacy of deep brain stimulation (DBS) of the subthalamic nucleus (STN) in advanced Parkinson’s disease. Methods: We performed a double blind crossover evaluation of the efficacy of DBS of the STN in the “off” medication condition in 10 patients with Parkinson’s disease. Assessments included the Unified Parkinson’s Disease Rating Scale (UPDRS) part III (motor) and two timed tests (arm tapping and walking). Open evaluation of the effect of stimulation in the off and on drug states preoperatively and at 1 and 4 years postoperatively was also conducted. The latter assessment included the UPDRS parts II (activities of daily living) and III (dyskinesia scale and global assessment) as judged by the patient and examiner. The mean amount of levodopa daily dose at base line, 1 year, and 4 years after surgery was compared. Results: A significant (p<0.04) effect of stimulation was observed in the overall group regarding both the UPDRS motor and the timed tests. Open evaluation also showed a significant benefit of STN DBS with respect to preoperative assessment in both the motor and activities of daily living scales, dyskinesia scale, and in global assessment. Levodopa daily dose was reduced by 48% and 50% at 1 and 4 years, respectively. There was no difference between the 1 and 4 years evaluations in any of the parameters evaluated. Complications due to stimulation were minor. Conclusions: DBS of the STN provides a significant and persistent anti-parkinsonian effect in advanced Parkinson’s disease 4 years after surgery.

[1]  D. Brooks,et al.  Core assessment program for intracerebral transplantations (CAPIT) , 1992, Movement disorders : official journal of the Movement Disorder Society.

[2]  H Fankhauser,et al.  Efficiency and safety of bilateral contemporaneous pallidal stimulation (deep brain stimulation) in levodopa-responsive patients with Parkinson's disease with severe motor fluctuations: a 2-year follow-up review. , 1998, Journal of neurosurgery.

[3]  V Sturm,et al.  Bilateral high‐frequency stimulation of the internal globus pallidus in advanced Parkinson's disease , 1998, Annals of neurology.

[4]  A. Benabid,et al.  Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. , 1998, The New England journal of medicine.

[5]  A. Lang,et al.  Double-blind evaluation of subthalamic nucleus deep brain stimulation in advanced Parkinson's disease , 1998, Neurology.

[6]  J. Obeso,et al.  Bilateral deep brain stimulation of the subthalamic nucleus in Parkinson's disease. , 2000, Neurology.

[7]  A. Tröster,et al.  Health-Related Quality of Life in Parkinson's Disease after Pallidotomy and Deep Brain Stimulation , 2000, Brain and Cognition.

[8]  A. Lozano,et al.  Targeting the basal ganglia for deep brain stimulation in Parkinson's disease. , 2000, Neurology.

[9]  Fukaya,et al.  Double blinded evaluation of the effects of pallidal and subthalamic nucleus stimulation on daytime activity in advanced Parkinson's disease. , 2000, Parkinsonism & related disorders.

[10]  P. Krack,et al.  Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease. , 2001, The New England journal of medicine.

[11]  Y Agid,et al.  Behavioural disorders, Parkinson's disease and subthalamic stimulation , 2002, Journal of neurology, neurosurgery, and psychiatry.

[12]  A. Benabid,et al.  Predictors of effective bilateral subthalamic nucleus stimulation for PD , 2002, Neurology.

[13]  R. Brown,et al.  Behavioural disorders, Parkinson's disease, and subthalamic stimulation , 2002, Journal of neurology, neurosurgery, and psychiatry.

[14]  A L Benabid,et al.  Bilateral subthalamic nucleus stimulation improves health-related quality of life in PD , 2002, Neurology.

[15]  A. Bentivoglio,et al.  Long-term follow up of subthalamic nucleus stimulation in Parkinson's disease. , 2002, Neurology.

[16]  J. Ghika,et al.  Subthalamic DBS replaces levodopa in Parkinson’s disease: Two-year follow-up , 2002, Neurology.

[17]  Subthalamic stimulation for Parkinson's disease--living better electrically? , 2003, The New England journal of medicine.

[18]  J. Villemure,et al.  How do parkinsonian signs return after discontinuation of subthalamic DBS? , 2003, Neurology.

[19]  J. Saint-Cyr,et al.  Long-term follow up of bilateral deep brain stimulation of the subthalamic nucleus in patients with advanced Parkinson disease. , 2003, Journal of neurosurgery.

[20]  Gordon H Baltuch,et al.  Deep brain stimulation for movement disorders: morbidity and mortality in 109 patients. , 2003, Journal of neurosurgery.

[21]  G. Linazasoro Subthalamic deep brain stimulation for advanced Parkinson’s disease: all that glitters is not gold , 2003, Journal of neurology, neurosurgery, and psychiatry.

[22]  B Conrad,et al.  A novel quality of life instrument for deep brain stimulation in movement disorders , 2003, Journal of neurology, neurosurgery, and psychiatry.

[23]  Tipu Aziz,et al.  Estimating the costs of surgical innovations: The case for subthalamic nucleus stimulation in the treatment of advanced Parkinson's disease , 2003, Movement disorders : official journal of the Movement Disorder Society.

[24]  A. Benabid,et al.  Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. , 2003, The New England journal of medicine.

[25]  K. Lyons,et al.  Bilateral subthalamic stimulation in patients with Parkinson disease: long-term follow up. , 2003, Journal of neurosurgery.